University of Massachusetts, Worcester
398
41
61
263
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
9.3%
37 terminated/withdrawn out of 398 trials
87.7%
+1.1% vs industry average
9%
34 trials in Phase 3/4
43%
113 of 263 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (398)
Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers
Role: lead
Zambia Healthy Choices Project for Emerging Adults Living With HIV
Role: lead
Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy
Role: collaborator
Adapting a Health at Every Size Intervention to Obstetric Care
Role: lead
Lifestyle Change Implementation Research Network at PRC at UMass Chan
Role: lead
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Role: collaborator
The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)
Role: lead
Pediatric Delirium
Role: lead
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
Role: collaborator
Food is Medicine in Pediatric Patients With Diabetes
Role: lead
Reaching Calm: A Digital Intervention to Prevent Perinatal Anxiety Disorders
Role: lead
Multisystemic Therapy-Emerging Adults Trial
Role: lead
Improving the Part C Early Intervention Service Delivery System for Children With ASD
Role: collaborator
ARISe at UMass Chan
Role: lead
Supporting Treatment Access and Recovery in Re-entry (STAR-R)
Role: lead
Re-Engineered Discharge for Diabetes Care Transitions
Role: lead
Tobacco Cessation Texting Intervention for People Living With HIV Who Smoke in Vietnam
Role: lead
Patient-Centered Practical Vaccine Talk For Busy Clinicians
Role: lead
Telehealth to Improve Prevention of Suicide (TIPS)
Role: lead
Preventing T2DM After GDM With Immediate Postpartum Screening
Role: lead